VEGF/VEGFR inhibitors

GS JT Pill - gray capsule-shape, 14mm

Generic Name: pazopanib

Pill with imprint GS JT is Gray, Capsule-shape and has been identified as Votrient pazopanib 200 mg. It is supplied by GlaxoSmithKline.

Votrient is used in the treatment of Soft Tissue Sarcoma; Renal Cell Carcinoma and belongs to the drug class VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Votrient pazopanib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Votrient (Pazopanib [ paz-oh-pa-nib ])-GS JT-pazopanib 200 mg-Gray-Capsule-shape
Votrient (Pazopanib [ paz-oh-pa-nib ])-GS JT-pazopanib 200 mg-Gray-Capsule-shape

Votrient
Generic Name: pazopanib [ paz-oh-pa-nib ]
Imprint: GS JT
Strength: pazopanib 200 mg
Color: Gray
Size: 14.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: VEGF/VEGFR inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Magnesium stearate, Microcrystalline cellulose, Povidone, Sodium starch glycolate type A potato, Hypromelloses, Ferrosoferric oxide, Polyethylene glycol 400, Polysorbate 80, Titanium dioxide,
Latest News
Related Drugs